AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

The Effect of Upper Limb Low-intensity Motor Control Training Program on Cognitive Function in Healthy Older Adults

RecruitingNAAges 65 Years - 85 YearsAllUniversity of Nottingham
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This healthy volunteer intervention study is designed to evaluate the effectiveness of upper limb motor control training (uMCT) on physical and cognitive functions in older adults. The primary objectives of the study are twofold: Assess the Impact on Physical and Neuromuscular Function: The study seeks to determine whether uMCT positively influences physical performance, including motor coordination and neuromuscular function, in older adults. Assessment the Impact on Cognitive Function: The study aims to investigate whether uMCT enhances cognitive abilities in older adults. In addition to these main goals, the study will also assess the feasibility and safety of implementing uMCT in an older adult population. The main questions it aims to answer are: Does uMCON training have a positive effect on physical function and neuromuscular function in older adults? Does uMCON training have

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * โ€ข Willing and able to give informed consent for participation in the study * Aged between 65-85 years Exclusion Criteria: * โ€ข Diagnosis of cognitive impairment * Current or recent (\<5y) malignancy * History of or current psychiatric illness * History of or current neurological condition (e.g., epilepsy, Parkinsons disease, cerebrovascular disease) * Severe respiratory disease (e.g., uncontrolled asthma, COPD, pulmonary hypertension) * Active cardiovascular disease: Uncontrolled hypertension (BP\>160/100mmHg); Recent (\<12mo) cardiac event; Heart failure (Class III/IV); Significant arrhythmia; Unstable angina * Metabolic disease: Untreated hyper/hypo-parathyroidism; Cushing's disease; Type 1 or 2 diabetes * Significant musculoskeletal disorders (based on clinical opinion) * Family history of early (\<55y) death from cardiovascular disease
๐Ÿ’Š

What it tests

  • Upper limb motor control training (uMCON)
๐Ÿ“

Where

1 site
The University of Nottingham Medical School
Derby, United Kingdom
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy